Eli Lilly and Co (NYSE:LLY) over-valued by 37%
| Website | https://www.lilly.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $188,458,008,576 |
| Beta | 0.261996 |
| Average Volume | $3,357,147 |
| Last Dividend | 3.18% |
| Price on Nov 1, 2022 | $352.58 |
| Autochartist™ Valuation | $222.76 |
| Conclusion |
37% over-valued |
| Download Report |
